Disease: Thrombotic thrombocytopenic purpura- congenital
- 100 Years of Thrombotic Thrombocytopenic Purpura: A Story of Death and Life
- A Case of Pregnancy-Induced Hereditary Thrombotic Thrombocytopenic Purpura Complicated by Cerebral Vasospasm
- A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry
- A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura
- Acquired thrombotic thrombocytopenic purpura as a clinical manifestation of pulmonary tuberculosis: a case report
- Acquired thrombotic thrombocytopenic purpura during durvalumab monotherapy for non-small cell lung cancer
- Acquired Thrombotic Thrombocytopenic Purpura in the Presence of a Urinary Tract Infection: A Rare Pediatric Case
- ADAMTS-13 conformation influences autoimmune recognition in immune thrombotic thrombocytopenic purpura
- ADAMTS13 conformation influences autoimmune recognition in immune thrombotic thrombocytopenic purpura
- ADAMTS13 RECOVERY IN ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA AFTER CAPLACIZUMAB THERAPY. THE SPANISH REGISTRY
- ADAMTS13-Mediated Proteolytic Cleavage of Unusually Large von Willebrand Factor Polymers on Endothelial Cells in the Absence of Fluid Shear Stress
- Adult Vitamin B12 Deficiency-Associated Pseudo-Thrombotic Microangiopathy: A Systematic Review of Case Reports
- Advances in pathophysiology, diagnosis and treatment of adult severe-associated thrombotic microangiopathy
- Alemtuzumab-induced immune-mediated thrombotic thrombocytopenic purpura: A newly described drug-related autoimmune disease
- Altered Mental Status in the Setting of Thrombotic Thrombocytopenic Purpura (TTP) and Spontaneous Coronary Artery Dissection (SCAD): A Case Report and Literature Review
- ANCA-Associated Vasculitis with Systemic Thrombotic Microangiopathy: A Review of Literature
- Apadamtase Alfa: First Approval
- Autoimmune thrombotic thrombocytopenic purpura associated with disseminated sarcoidosis: A case report
- Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine
- Cancer-related thrombotic microangiopathy and disseminated intravascular coagulation in a patient with bone marrow carcinomatosis of unknown primary origin: A case report
- Case report: Thrombotic thrombocytopenic purpura in a pregnant woman with lupus membranous nephropathy: a diagnostic challenge
- Clinical characteristics, treatments, and outcomes of interferon-beta-induced thrombotic microangiopathy: a literature-based retrospective analysis
- Cognitive decline in thrombotic thrombocytopenic purpura survivors: The role of white matter health as assessed by MRI
- Concomitant presentation of thrombotic thrombocytopenic purpura, immune thrombocytopenia, and autoimmune hemolytic anemia in a patient with newly diagnosed systemic lupus erythematosus
- Concurrent myocardial infarction in the setting of thrombotic thrombocytopenic purpura secondary to systemic lupus erythematosus: A case report
- Congenital thrombotic thrombocytopenic purpura diagnosed in adulthood after repeated thrombocytopenia since neonatal period
- Cost-effectiveness of rapid vs. in-house vs. send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura
- COVID-Induced Thrombotic Thrombocytopenic Purpura: A Case Report and Treatment-Focused Review
- CRE24-050: Microangiopathic Hemolytic Anemia as the Presenting Manifestation of Metastatic Breast Cancer
- Damage-associated cellular markers in the clinical and pathogenic profile of vaccine-induced immune thrombotic thrombocytopenia
- De-novo immune-mediated thrombotic thrombocytopenic purpura following surgical and non-surgical procedures: A systematic review
- Developing International Classification of Disease code definitions for the study of enteric infection sequelae in Canada
- Diagnosis of thrombotic thrombocytopenic purpura: Easy-to-use fiber-optic surface plasmon resonance immunoassays for automated ADAMTS13 antigen and conformation evaluation
- Distinguishing thrombotic thrombocytopenic purpura from primary immune thrombocytopenia accompanied by anemia using the carbon monoxide breath test
- Does Caplacizumab for the management of thrombotic thrombocytopenic purpura increase the risk of relapse, exacerbation, and bleeding? An updated systematic review and meta-analysis based on revised criteria by the International Working Group for thromboti
- HELLP Syndrome and Differential Diagnosis with Other Thrombotic Microangiopathies in Pregnancy
- Hematological Complications of Human Immunodeficiency Virus (HIV) Infection: An Update From an HIV-Endemic Setting
- Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P's) for anti-PF4 diseases
- Hemolytic Anemia and Pancytopenia Secondary to Vitamin B12 Deficiency: Evaluation and Clinical Significance
- Hemolytic Uremic Syndrome
- HHV8-Positive Multicentric Castleman's Disease and Thrombotic Thrombocytopenic Purpura among HIV-Positive Patients
- HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies
- How Should Complicated Cases of Thrombotic Thrombocytopenic Purpura With Positive Coombs Test Be Treated?
- Hump-Nosed Viper Bite-Associated Thrombotic Thrombocytopenic Purpura: A Rare Complication
- Immune thrombocytopaenic purpura following COVID-19 infection masquerading as senile purpura
- Immune-mediated thrombotic thrombocytopenic purpura: don't miss the boat
- Impact of Concomitant Thrombotic Thrombocytopenic Purpura on COVID-19 Mortality and Morbidity: A Nationwide Inpatient Sample Analysis
- In vitro test methods for evaluating high molecular weight polyethylene oxide polymer induced hemolytic and thrombotic potential
- Indirect causes of maternal deaths (except stroke, cardiovascular diseases and infections) in France 2016-2018
- Indirects causes of maternal deaths (except stroke, cardiovascular diseases and infections) in France 2016-2018
- Induction of thrombotic thrombocytopenic purpura by dengue virus infection in a critical patient: Role of therapeutic plasma exchange
- Largest comparison between onset and relapses of acquired thrombotic thrombocytopenic purpura reveals severe neurological involvement and worse analytic parameters at debut
- Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura
- Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia
- Management of pediatric hemolytic uremic syndrome
- Managing Fresh-Frozen Plasma Transfusion Adverse Effects: Allergic Reactions, TACO, and TRALI
- Mechanism underlying severe deficiency of plasma ADAMTS-13 activity in immune thrombotic thrombocytopenic purpura
- Mechanism underlying severe deficiency of plasma ADAMTS13 activity in immune thrombotic thrombocytopenic purpura
- Mortality, cardiac and cerebral damages reduction by IL-1 inhibition in a murine model of TTP
- NEPHRO-ZEBRA-a neonate with severe jaundice, persistent thrombocytopenia & recurrent acute kidney injury later in childhood: Joining the dots!
- Nivolumab-induced Thrombotic Thrombocytopenic Purpura in Patients with Gastric Tube Cancer
- Outcomes and Costs in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving Front-Line Versus Delayed Caplacizumab: A US Hospital Database Study
- Outcomes of thrombotic thrombocytopenic purpura patients submitted to therapeutic plasma exchange in a single center in Brazil
- Paediatric patients with suspected immune thrombotic thrombocytopenic purpura also experience treatment delays
- Pathological Mechanisms and Novel Testing Methods in Thrombotic Thrombocytopenic Purpura
- Pattern of Bone Marrow Hypometabolism on 18 F-FDG PET CT in Systemic Lupus Erythematous-Associated Aplastic Anemia
- Pattern of Bone Marrow Hypometabolism on 18F-FDG PET CT in Systemic Lupus Erythematous-Associated Aplastic Anemia
- Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated Thrombotic Thrombocytopenic Purpura
- Persistent ADAMTS13 Inhibitor Delays Recovery of ADAMTS13 activity in Caplacizumab-Treated Japanese iTTP Patients
- Plasma cell-directed therapy strategies in immune-mediated thrombotic thrombocytopenic purpura (iTTP)
- Plasmin-cleaved Von Willebrand Factor as a biomarker for microvascular thrombosis
- Plasmodium falciparum Malaria Presenting as a Thrombotic Thrombocytopenic Purpura (TTP) Mimic: A Case Report
- Pregnancy as a susceptible state for thrombotic microangiopathies
- Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities
- Progress in the clinical effects and adverse reactions of ticagrelor
- Pseudo-thrombotic Microangiopathy - An Unusual Presentation of Cobalamin Deficiency
- Real-World Data Analysis of Patients Affected by Immune-Mediated Thrombotic Thrombocytopenic Purpura in Italy
- Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura
- Risk-based and individualised management of bleeding and thrombotic events in adults with primary immune thrombocytopenia (ITP)
- Schistocyte detection in artificial intelligence age
- Shades of Grey-The brain in TTP
- Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons
- Stress-induced hyperglycemia is associated with the mortality of thrombotic thrombocytopenic purpura patients
- Structural Characterization of a Pathogenic Antibody Underlying Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
- Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab
- Successful Treatment of Acquired Thrombotic Thrombocytopenic Purpura With Caplacizumab Combined With Plasma Exchanges and Immune Suppression in 3 Children
- Targeted ADAMTS-13 replacement therapy for thrombotic thrombocytopenic purpura
- Targeting Neutrophil Extracellular Trap under Flow in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura
- The latest insights into rare blood disorders: Diagnosis and treatment strategies
- The thrombin generation capability of the Chacma baboon (Papio ursinus): implications for haemostatic disease models
- The TTP specialist nurse: an advocate for patients and professionals
- Thrombocytopenic thrombotic purpura related to COVID-19 vaccine: apropos of 4 cases
- Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta-analysis of randomized controlled trials
- Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta‑analysis of randomized controlled trials
- Thrombotic complications of immune thrombocytopenic purpura
- Thrombotic Thrombocytopenic Purpura due to Varicella-Zoster Virus Meningoencephalitis in an Immunocompetent Patient
- Thrombotic Thrombocytopenic Purpura Evaluation and Management
- Thrombotic thrombocytopenic purpura: optimal management of plasma exchange, platelets and infection prevention
- Treatment of immune-mediated thrombotic thrombocytopenic purpura without plasma exchange
- Types of plasma exchange solution in the new scenario of thrombotic thrombocytopenic purpura treatment